Test Price
2,800 AED✅ Home Collection Available
CAV3 Gene Familial Hypertrophic Cardiomyopathy (HCM) Genetic Test in UAE | 2,800 AED | DNA Labs UAE
Executive Summary & Core Metrics
This advanced CAV3 gene analysis using next-generation sequencing delivers precise molecular diagnosis for familial hypertrophic cardiomyopathy, supported by premium home collection logistics and expert post-test clinical guidance. Fully compliant with UAE healthcare regulations and international quality standards.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO Accredited Processing.
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection (Available daily from 8 AM to 11 PM).
- Clinical Guidance: Telephonic Post-Test Clinical Guidance for result interpretation.
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
Test Overview & Methodology
The CAV3 gene test employs next-generation sequencing to detect pathogenic variants associated with familial hypertrophic cardiomyopathy. Full gene coverage, copy number variation detection, and a minimum read depth of 100× ensure robust and definitive molecular results for at-risk individuals and families. This test is specifically designed for patients with a personal or family history suggestive of hypertrophic cardiomyopathy who require confirmatory genetic analysis.
| Feature | Our CAV3 Genetic Test | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Precision / Method | NGS – full gene coverage, CNV detection, 100× read depth | Sanger – limited to coding exons, no CNV analysis |
| Diagnostic Sensitivity | 99.9% for SNVs, indels, and deep intronic variants | ~90–95% (misses non‑coding variants) |
| Turnaround Time | 3 to 4 Weeks | 4 to 6 Weeks |
Physician Insight & Safety Protocols
“Understanding your genetic predisposition through this CAV3 gene analysis is a powerful step toward proactive cardiac care. A positive finding is not a definitive diagnosis but a critical indicator that warrants comprehensive clinical evaluation and family cascade screening. Always interpret results within the context of your complete medical and family history.”
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Advisory Notice
Medication Warning
Do not discontinue prescribed medication without consulting your doctor. Genetic test results should complement, not replace, your current treatment plan.
Exclusion Criteria & Emergency Red Flags
- Inability to provide informed consent (guardian consent and pre-test genetic counseling mandatory for minors per Federal Decree-Law No. 4 of 2016 on Medical Liability).
- Absence of a pre-test genetic counseling session with a certified clinical geneticist.
- Active severe psychiatric condition impeding understanding of test implications.
- Emergency Red Flags: If you experience sudden chest pain, palpitations, fainting (syncope), or severe shortness of breath, seek emergency care immediately.
Patient FAQ & Clinical Guidance
1. What is the CAV3 gene and how does it relate to hypertrophic cardiomyopathy?
The CAV3 gene produces caveolin-3, a protein essential for heart muscle cell membrane organization. Pathogenic variants in CAV3 cause familial hypertrophic cardiomyopathy with elevated risk of arrhythmia and sudden cardiac death. This test identifies those at-risk individuals, enabling early intervention and tailored family screening.
2. Who should consider this genetic test in the UAE?
Any person with a family history of hypertrophic cardiomyopathy, unexplained cardiac events, or athletes undergoing pre-participation cardiac screening should consider this test after expert genetic counselling. First-degree relatives of a known CAV3 variant carrier are strongly advised to pursue testing.
3. How is the sample collected, and what is the turnaround time?
A simple blood draw or buccal swab is collected at your home by a certified phlebotomist via our VIP mobile phlebotomy service with temperature-controlled cold-chain logistics. The complete NGS analysis and clinical interpretation are delivered within 3 to 4 weeks.
UAE Regulatory & Data Privacy Adherence
✓ ISO 9001:2015 Certified (Cert: INT/EGQ/2509DA/3139) | Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) | Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields | Federal Decree-Law No. 4 of 2016 on Medical Liability | DHA Licensed Facility 1143
Clinical & Logistical Metadata
| Test Name | CAV3 Gene Familial Hypertrophic Cardiomyopathy (HCM) Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (EDTA) or buccal swab |
| Methodology Used | Next-Generation Sequencing (NGS) – full gene coverage, CNV detection, 100× read depth |
| ICD-10-CM Code | I42.1 (Obstructive hypertrophic cardiomyopathy) |
| LOINC Code | 21636-6 (Hypertrophic cardiomyopathy genetic testing panel) |
| DHA Facility License & Address | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE | DNA Labs UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians